aspirin has been researched along with Postthrombotic Syndrome in 4 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Postthrombotic Syndrome: A condition caused by one or more episodes of DEEP VEIN THROMBOSIS, usually the blood clots are lodged in the legs. Clinical features include EDEMA; PAIN; aching; heaviness; and MUSCLE CRAMP in the leg. When severe leg swelling leads to skin breakdown, it is called venous STASIS ULCER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this open, observational registry was to evaluate the effects of antithrombotic treatment on the development of postthrombotic syndrome (PTS): the effects of "standard management" (SM; according to International Union of Angiology guidelines) were compared to SM in association with sulodexide or aspirin." | 5.19 | The efficacy of sulodexide in the prevention of postthrombotic syndrome. ( Agus, G; Arpaia, G; Belcaro, G; Cesarone, MR; Cornelli, U; Corsi, M; Cotellese, R; Dugall, M; Errichi, BM; Hosoi, M; Hu, S; Ippolito, E; Ledda, A; Luzzi, R; Ricci, A, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belcaro, G | 2 |
| Dugall, M | 2 |
| Hu, S | 2 |
| Feragalli, B | 1 |
| Cotellese, R | 2 |
| Ledda, A | 2 |
| Corsi, M | 2 |
| Ricci, A | 2 |
| Ippolito, E | 2 |
| Errichi, BM | 2 |
| Cornelli, U | 2 |
| Cesarone, MR | 2 |
| Hosoi, M | 2 |
| Prandoni, P | 1 |
| Barbar, S | 1 |
| Milan, M | 1 |
| Vedovetto, V | 1 |
| Pesavento, R | 1 |
| Luzzi, R | 1 |
| Arpaia, G | 1 |
| Agus, G | 1 |
| Gokce, M | 1 |
| Altan, I | 1 |
| Unal, S | 1 |
| Kuskonmaz, B | 1 |
| Aytac, S | 1 |
| Cetin, M | 1 |
| Tuncer, M | 1 |
| Gumruk, F | 1 |
| Gurgey, A | 1 |
1 review available for aspirin and Postthrombotic Syndrome
| Article | Year |
|---|---|
The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities.
Topics: Age Factors; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Dabigatran; Disease Management; | 2014 |
1 trial available for aspirin and Postthrombotic Syndrome
| Article | Year |
|---|---|
The efficacy of sulodexide in the prevention of postthrombotic syndrome.
Topics: Adult; Anticoagulants; Aspirin; Female; Fibrinolytic Agents; Glycosaminoglycans; Humans; Incidence; | 2014 |
2 other studies available for aspirin and Postthrombotic Syndrome
| Article | Year |
|---|---|
Prevention of recurrent venous thrombosis and post-thrombotic syndrome.
Topics: Aspirin; Drug Therapy, Combination; Female; Fibrinolytic Agents; Flavonoids; Glycosaminoglycans; Hum | 2018 |
Recurrent pediatric thrombosis: the effect of underlying and/or coexisting factors.
Topics: Adolescent; Adult; Anticoagulants; Aspirin; Child; Child, Preschool; Chronic Disease; Factor VIII; F | 2012 |